Skip to main content

Table 1 HCMV IgG seroprevalence in solid organ transplant recipients and healthy transplant donors by age distribution

From: Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea

Age (years)Anti-HCMV IgGSOT recipients (n = 2184)Healthy transplant donors (n = 3015)p-value
1–5Positive12 (80.0)0 (0)N/A
Negative3 (20.0)0 (0)
6–10Positive9 (75.0)0 (0)N/A
Negative3 (25.0)0 (0)
11–15Positive12 (70.6)0 (0)N/A
Negative5 (29.4)0 (0)
16–20Positive41 (93.2)46 (54.8)<0.001
Negative3 (6.8)38 (45.2)
21–25Positive54 (90.0)162 (63.3)<0.001
Negative6 (10.0)94 (36.7)
26–30Positive114 (96.6)262 (78.9)<0.001
Negative4 (3.4)70 (21.1)
31–35Positive133 (99.3)307 (86.5)<0.001
Negative1 (0.7)48 (13.5)
36–40Positive215 (99.1)229 (89.8)<0.001
Negative2 (0.9)26 (10.2)
41–60Positive1287 (99.8)1088 (94.3)<0.001
Negative2 (0.2)66 (5.7)
≥ 61Positive278 (100)576 (99.5)0.555
Negative0 (0)3 (0.5)
TotalPositive2155 (98.7)2670 (88.6)<0.001
Negative29 (1.3)345 (11.4)
  1. Data are expressed as number (percent). Abbreviations: HCMV Human cytomegalovirus, IgG immunoglobulin G, N/A not available, SOT solid organ transplantation